Skip to main content
Stuart Sealfon, MD, Neurology, New York, NY

StuartCSealfonMD

Neurology • New York, NY

Chairman Emeritus Neurology at Mount Sinai School of Medicine

Join to view full profile

Dr. Sealfon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sealfon's full profile

Already have an account?

  • Office

    5 E 98th St
    Fl 7
    New York, NY 10029
    Phone+1 212-241-4737
    Fax+1 212-348-1310

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1983 - 1986
  • Massachusetts General Hospital
    Massachusetts General HospitalInternship, Internal Medicine, 1982 - 1983
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1982

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1986 - 2025
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

Journal Articles

  • Tellurium Notebooks—an Environment for Reproducible Dynamical Modeling in Systems Biology  
    Stuart C. Sealfon, Stuart C. Sealfon, PLoS One

Press Mentions

  • Researchers Discover Behavior of Immunity Genes Leading to Worse COVID Outcomes for Men
    Researchers Discover Behavior of Immunity Genes Leading to Worse COVID Outcomes for MenNovember 14th, 2022
  • DARPA ECHO Program Testing Epigenome or DNA Changes for Tracking Exposure to Threat Agents, Weapons of Mass Destruction (WMD) on Battlefield
    DARPA ECHO Program Testing Epigenome or DNA Changes for Tracking Exposure to Threat Agents, Weapons of Mass Destruction (WMD) on BattlefieldSeptember 30th, 2021
  • Experts: Previous COVID-19 Infection Not a Get Out of Jail Free Card
    Experts: Previous COVID-19 Infection Not a Get Out of Jail Free CardJune 3rd, 2021
  • Join now to see all

Grant Support

  • Mount Sinai Neurology Resident-Researcher Training ProgramNational Institute Of Neurological Disorders And Stroke2012
  • GNRH Receptor Signaling SpecificityNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2012
  • Hallucinogens In Specific Signaling And CircuitryNational Institute On Drug Abuse2007–2011
  • GNRH Receptor Signaling SpecificityNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2009
  • GNRH Receptor Signaling SpecificityNational Institute Of Diabetes And Digestive And Kidney Diseases2006
  • Interdisciplinary Training In Drug Abuse ResearchNational Institute On Drug Abuse2001–2006
  • Cellular Responses To HallucinogensNational Institute On Drug Abuse2000–2002
  • Molecular Mechanism Of Agonism At The GNRH ReceptorNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2000
  • Receptor Determinants Of Hallucinogen ActionsNational Institute On Drug Abuse1997–1998
  • Evolution Of The GNRH Receptor And Its BindingFogarty International Center1997–1998
  • Evolution Of The GNRH Receptor And Its BindingFogarty International Center1996
  • Receptor Determinants Of Hallucinogen ActionsNational Institute On Drug Abuse1994–1996
  • Human GNRH Receptor--Determinants Of Ligand BindingNational Institute Of Diabetes And Digestive And Kidney Diseases1993–1996
  • Regulation Of Neuro-Hormone ReceptorsNational Institute Of Diabetes And Digestive And Kidney Diseases1988–1992

Dr. Stuart Sealfon, Dr. Stuart Sealfon, MD, Dr. S Sealfon, Dr. Stuart C Sealfon